PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\', \'CureVac AG, Tübingen, Germany. Susanne.rauch@curevac.com.\', \'CureVac AG, Tübingen, Germany.\', \'Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.\', \'University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.\', \'Bioqual, Rockville, MD, USA.\', \'Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Ragon Institute of MGH, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41586-021-04231-6
?:doi
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 34794169
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34794169>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34794169>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all